Official SEC submissions

Arcutis Biotherapeutics SEC Filings

Direct answer

Arcutis Biotherapeutics's latest SEC filing is 4.

It was filed on August 28, 2026, and 40 recent filings are available.
Each row links directly to the SEC document and filing index.
Official SEC EDGAR submissions

Get free Arcutis Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

10-Q

Periodic report

Filed:

Report date:

10-Q

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

4/A

Insider transaction

Filed:

Report date:

FORM 4/A

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

8-K

Current report

Filed:

Report date:

8-K

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

4

Insider transaction

Filed:

Report date:

FORM 4

Open SEC documentView filing index

144

Planned securities sale

Filed:

Open SEC documentView filing index

Verified data

Recent filing categories
4
Recent filings
40
SEC CIK
0001787306
Latest filing date
August 28, 2026

Explore related company data

View the Arcutis Biotherapeutics company profileView Arcutis Biotherapeutics annual financials